Loading…
Boston Scientific agreed to acquire Intera Oncology, a medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine for treating liver tumors. The acquisition expands Boston Scientific's interventional oncology offerings.
“Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Intera Oncology® Inc.”news.bostonscientific.com
Summarized from public sources; check the original articles before acting on it.